Skip to main content
Disease Markers logoLink to Disease Markers
. 2008 May 27;24(4-5):257–266. doi: 10.1155/2008/396281

Lung Cancer Stem Cells

Sharon R Pine 1, Blair Marshall 2, Lyuba Varticovski 1,*
PMCID: PMC3850541  PMID: 18525120

Abstract

Lung cancer remains a major cause of cancer-related lethality because of high incidence and recurrence in spite of significant advances in staging and therapies. Recent data indicates that stem cells situated throughout the airways may initiate cancer formation. These putative stem cells maintain protumorigenic characteristics including high proliferative capacity, multipotent differentiation, drug resistance and long lifespan relative to other cells. Stem cell signaling and differentiation pathways are maintained within distinct cancer types, and destabilization of this machinery may participate in maintenance of cancer stem cells. Characterization of lung cancer stem cells is an area of active research and is critical for developing novel therapies. This review summarizes the current knowledge on stem cell signaling pathways and cell markers used to identify the lung cancer stem cells.

Keywords: ABC transporters, drug resistance, hedgehog, notch, non-small cell lung cancer, side population, small cell lung cancer, stem cells, Wnt

Full Text

The Full Text of this article is available as a PDF (68.8 KB).


Articles from Disease markers are provided here courtesy of Wiley

RESOURCES